Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) HKSE

15.67

+0.08(+0.51%)

Updated at June 02 04:08PM

Currency In HKD

Valuation

Market Cap25.88B
Enterprise Value31.63B
P/E Ratio12.02
PEG Ratio1.25
Price/Sales Ratio0.45
Price/Book Ratio0.9
Enterprise/Revenue0.59
Enterprise/EBITDA12.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.04

Management Effectiveness

Return On Assets0.03
Return On Equity0.08

Income Statement

Revenue75.44B
Revenue/Share48.26
Gross Profit11.45B
EBITDA3.95B
Net Income2.91B
Diluted EPS1.79

Balance Sheet

Total Cash12.29B
Total Cash/Share7.58
Total Debt17.04B
Total Debt/Equity0.59
Current Ratio1.6
Book Value Per Share25.77

Price History

52-Week Change-9.63
52-Week High20.4
52-Week Low15.12
Moving Average 50 Days16.75
Moving Average 200 Days18.21

Statistics

Average Volume1.39M
Shares Outstanding2.48B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield3.67
Payout Ratio0.69
Last Split FactorN/A
Last Split DateN/A